Get the latest Science News and Discoveries

Obesity Treatment with Incretin-Based Therapies: A Favorable Benefit–Risk Balance with Manageable Safety Concerns

GLP-1RAs cause GI side effects; rare risks include pancreatitis, gallbladder disease, retinopathy. Safety is dose-dependent, patient-specific, needs monitoring.

None

Get the Android app